Euglena Co., Ltd.

Tokyo Stock Exchange 2931.T

Euglena Co., Ltd. EBITDA Margin for the year ending December 31, 2022: 1.52%

Euglena Co., Ltd. EBITDA Margin is 1.52% for the year ending December 31, 2022, a 115.87% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Euglena Co., Ltd. EBITDA Margin for the year ending September 30, 2021 was -9.59%, a -78.20% change year over year.
Euglena Co., Ltd. EBITDA Margin for the year ending September 30, 2020 was -5.38%, a 87.68% change year over year.
Euglena Co., Ltd. EBITDA Margin for the year ending September 30, 2019 was -43.72%, a -1,943.11% change year over year.
Euglena Co., Ltd. EBITDA Margin for the year ending September 30, 2018 was -2.14%, a -117.77% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Tokyo Stock Exchange: 2931.T

Euglena Co., Ltd.

CEO	Mr. Tomohiro Wakahara
IPO Date	Dec. 21, 2012
Location	Japan
Headquarters	G-BASE Tamachi
Employees	846
Sector	Energy
Industries Biofuel Biotechnology Fertilizers

Description

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae. It operates through Healthcare Business and Energy/Environment Business segments. The company also manufactures and sells foods and cosmetics using euglena. In addition, it offers health foods, beverages, confectionery, and sports food products. Further, the company develops biofuel technology and environmental related technology for microalgae; and invests in biotechnology related business. It distributes its products at convenience stores, drugstores, supermarkets, beauty salons, and variety shops. The company was incorporated in 2005 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years